ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2015

Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer.

Yihebali Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.